Side-by-side comparison of AI visibility scores, market position, and capabilities
British consumer health company with £14B revenue; Lysol, Mucinex, Nurofen, and Durex brands managing Mead Johnson infant formula litigation while competing with P&G and J&J.
Reckitt is a British multinational consumer health and hygiene company producing market-leading brands including Nurofen (ibuprofen), Strepsils, Dettol, Lysol, Durex, Mucinex, Enfamil infant formula, and Woolite — competing across OTC health, hygiene and home, and nutrition categories. Listed on the London Stock Exchange (LSE: RKT) and headquartered in Slough, England, Reckitt generates approximately £14 billion ($17 billion) in annual revenue. The company has undergone significant portfolio reshaping, divesting its Infant Formula & Child Nutrition (IFCN) business in some markets and selling Mead Johnson Nutrition operations.\n\nReckitt's business is organized into two segments: Health (Nurofen, Strepsils, Gaviscon, Mucinex, DayQuil/NyQuil in North America) and Hygiene and Home (Lysol/Dettol disinfectants, Finish dishwasher tablets, Vanish stain remover, Air Wick). The Health segment benefits from strong brand equity in OTC medications that command premium pricing. The Hygiene segment's Lysol brand benefited significantly from COVID-19 disinfectant demand and has sustained elevated brand awareness post-pandemic.\n\nIn 2025, Reckitt faces ongoing challenges from its $2.4 billion acquisition of Mead Johnson (Enfamil) — the company has faced significant litigation related to NEC (necrotizing enterocolitis) lawsuits claiming preterm infant formula contributed to infant deaths, resulting in large court judgments against Reckitt in 2024. The company is managing these legal liabilities while continuing to run its core consumer health and hygiene portfolio. Reckitt competes with Procter & Gamble, Johnson & Johnson, and Haleon for OTC health and hygiene market share. The 2025 strategy focuses on its Power Brands in health and hygiene, cost efficiency, and resolving the Mead Johnson litigation exposure.
Global entertainment giant with $91.4B FY2024 revenue; Disney+ profitable 2024; Hulu 100% owned; ESPN DTC launch planned 2025; Experiences/parks at record levels; Peltz proxy fight won.
The Walt Disney Company is one of the world's largest entertainment and media conglomerates, founded in 1923 by Walt and Roy Disney in Los Angeles and now headquartered in Burbank, California, trading on NYSE (DIS). The company reported approximately $91.4 billion in revenues for fiscal year 2024 (ending September 28) under CEO Bob Iger, who returned to lead the company in November 2022 following a turbulent period under Bob Chapek. Iger's second tenure has focused on restoring Disney's creative culture, achieving streaming profitability, and restructuring the linear television portfolio as cord-cutting accelerates. Disney+ achieved its first quarterly profitability milestone in late 2023 and sustained profitability through FY2024, while ESPN's eventual direct-to-consumer streaming launch—planned for fall 2025—represents the most consequential strategic transition in Disney's recent history.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.